Biologic-Based Therapies in IBD

Content Type: presentation

Presenter: Sunanda V. Kane, MD, MSPH, FACG

Presenter Disclosure: Consultant: AbbVie, Merck, Seres Therapeutics, Spherix Health Selection Committee: Sherman Foundation

Event: 2018 ACG Postgraduate Course

Release Date: 6/16/2019

Expiration Date: 6/16/2022

Objective: Review current biologic agents for IBD, including biosimilars.